Renalytix Plc Stock Current Ratio
RTNXF Stock | USD 0.62 0.00 0.00% |
Renalytix Plc fundamentals help investors to digest information that contributes to Renalytix Plc's financial success or failures. It also enables traders to predict the movement of Renalytix Pink Sheet. The fundamental analysis module provides a way to measure Renalytix Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Renalytix Plc pink sheet.
Renalytix |
Renalytix Current Ratio Analysis
Renalytix Plc's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Renalytix Plc Current Ratio | 2.48 X |
Most of Renalytix Plc's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Renalytix Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition |
In accordance with the recently published financial statements, Renalytix Plc has a Current Ratio of 2.48 times. This is 14.78% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The current ratio for all United States stocks is 14.81% lower than that of the firm.
Renalytix Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Renalytix Plc's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Renalytix Plc could also be used in its relative valuation, which is a method of valuing Renalytix Plc by comparing valuation metrics of similar companies.Renalytix Plc is currently under evaluation in current ratio category among related companies.
Renalytix Fundamentals
Return On Equity | -1.2 | |||
Return On Asset | -0.63 | |||
Operating Margin | (15.38) % | |||
Current Valuation | 53.6 M | |||
Shares Outstanding | 93.61 M | |||
Shares Owned By Insiders | 40.87 % | |||
Shares Owned By Institutions | 10.67 % | |||
Price To Earning | 10.53 X | |||
Price To Book | 2.91 X | |||
Price To Sales | 25.80 X | |||
Revenue | 2.97 M | |||
Gross Profit | 874 K | |||
EBITDA | (52.81 M) | |||
Net Income | (45.28 M) | |||
Cash And Equivalents | 32.36 M | |||
Cash Per Share | 0.45 X | |||
Total Debt | 7.68 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 2.48 X | |||
Book Value Per Share | 0.25 X | |||
Cash Flow From Operations | (45.92 M) | |||
Earnings Per Share | (0.60) X | |||
Number Of Employees | 102 | |||
Beta | 2.05 | |||
Market Capitalization | 163.83 M | |||
Total Asset | 50.06 M | |||
Z Score | 9.3 | |||
Net Asset | 50.06 M |
About Renalytix Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Renalytix Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Renalytix Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Renalytix Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York. Renalytix Plc operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 51 people.
Currently Active Assets on Macroaxis
Check out Renalytix Plc Piotroski F Score and Renalytix Plc Altman Z Score analysis. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Renalytix Pink Sheet analysis
When running Renalytix Plc's price analysis, check to measure Renalytix Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix Plc is operating at the current time. Most of Renalytix Plc's value examination focuses on studying past and present price action to predict the probability of Renalytix Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix Plc's price. Additionally, you may evaluate how the addition of Renalytix Plc to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |